Biopharma/Biotech Analyst Chen and Biotech Analysts Schmidt, Schimmer & Watsek, along with Dr. Sabari of NYU Langone Health System discuss which antibody drug conjugates are changing the treatment paradigm in oncology (relevant companies: PFE SGEN AMAM MRK JNJ LLY IMGN BCYC VINC MRSN ZYME) on an Analyst/Industry conference call to be held on November 17 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PFE:
- Ex-Dividend Date Nearing for These 10 Stocks – Week of November 6-10, 2023
- Actinium Pharmaceuticals names Lynn Bodarky as Chief Business Officer
- Pfizer reports 39 presentations spanning ten medicines at ASH
- Eterna appoints Bristol to board of directors
- Pfizer price target lowered to $34 from $35 at Barclays
